These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22404285)

  • 41. Is Propensity Score Analysis a Valid Surrogate of Randomization for the Avoidance of Allocation Bias?
    Torres F; Ríos J; Saez-Peñataro J; Pontes C
    Semin Liver Dis; 2017 Aug; 37(3):275-286. PubMed ID: 28847037
    [No Abstract]   [Full Text] [Related]  

  • 42. Yes, size does matter!: Sample size calculations for randomised trials.
    Middleton L
    BJOG; 2020 Jul; 127(8):1016-1017. PubMed ID: 31910329
    [No Abstract]   [Full Text] [Related]  

  • 43. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations.
    Hannan EL
    JACC Cardiovasc Interv; 2008 Jun; 1(3):211-7. PubMed ID: 19463302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CONSORT 2010 statement: extension to randomised crossover trials.
    Dwan K; Li T; Altman DG; Elbourne D
    BMJ; 2019 Jul; 366():l4378. PubMed ID: 31366597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Credibility of claims of subgroup effects in randomised controlled trials: systematic review.
    Sun X; Briel M; Busse JW; You JJ; Akl EA; Mejza F; Bala MM; Bassler D; Mertz D; Diaz-Granados N; Vandvik PO; Malaga G; Srinathan SK; Dahm P; Johnston BC; Alonso-Coello P; Hassouneh B; Walter SD; Heels-Ansdell D; Bhatnagar N; Altman DG; Guyatt GH
    BMJ; 2012 Mar; 344():e1553. PubMed ID: 22422832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical trials methodology: randomization, intent-to-treat, and random-effects regression.
    Atkins DC
    Depress Anxiety; 2009; 26(8):697-700. PubMed ID: 19658122
    [No Abstract]   [Full Text] [Related]  

  • 47. Statistics notes: missing outcomes in randomised trials.
    Vickers AJ; Altman DG
    BMJ; 2013 Jun; 346():f3438. PubMed ID: 23744649
    [No Abstract]   [Full Text] [Related]  

  • 48. Sample size determination and statistical power in randomized controlled trials.
    Sjögren P; Hedström L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):652-3. PubMed ID: 20416528
    [No Abstract]   [Full Text] [Related]  

  • 49. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods.
    Graves N; Walker D; Raine R; Hutchings A; Roberts JA
    Health Econ; 2002 Dec; 11(8):735-9. PubMed ID: 12457373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving the quality of reporting in randomised controlled trials.
    Walker A; Nixon J
    J Wound Care; 2004 Mar; 13(3):103-6. PubMed ID: 15045804
    [No Abstract]   [Full Text] [Related]  

  • 51. Multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level.
    Rombach I; Gray AM; Jenkinson C; Murray DW; Rivero-Arias O
    BMC Med Res Methodol; 2018 Aug; 18(1):87. PubMed ID: 30153796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extrapolating evidence beyond age groups.
    Bisgaard H; Bønnelykke K
    J Allergy Clin Immunol; 2008 Apr; 121(4):1066-7; author reply 1067-8. PubMed ID: 18325574
    [No Abstract]   [Full Text] [Related]  

  • 53. Randomized two-stage Phase II clinical trial designs based on Barnard's exact test.
    Shan G; Ma C; Hutson AD; Wilding GE
    J Biopharm Stat; 2013; 23(5):1081-90. PubMed ID: 23957517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing quality of reports on randomized clinical trials in nursing journals.
    Parent N; Hanley JA
    Can J Cardiovasc Nurs; 2009; 19(2):25-39. PubMed ID: 19517902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On model selections for repeated measurement data in clinical studies.
    Zou B; Jin B; Koch GG; Zhou H; Borst SE; Menon S; Shuster JJ
    Stat Med; 2015 May; 34(10):1621-33. PubMed ID: 25645442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Korn and Freidlin's misunderstanding of the null hypothesis significance testing procedure.
    Trafimow D; Rice S
    Am J Bioeth; 2011 Mar; 11(3):15-6. PubMed ID: 21400377
    [No Abstract]   [Full Text] [Related]  

  • 57. Bayesian Analysis: A Practical Approach to Interpret Clinical Trials and Create Clinical Practice Guidelines.
    Bittl JA; He Y
    Circ Cardiovasc Qual Outcomes; 2017 Aug; 10(8):. PubMed ID: 28798016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Designing randomised trials: both large and small trials are needed.
    Stenning SP; Parmar MK
    Ann Oncol; 2002; 13 Suppl 4():131-8. PubMed ID: 12401679
    [No Abstract]   [Full Text] [Related]  

  • 59. Confirmatory clinical trials with an adaptive design.
    Koch A
    Biom J; 2006 Aug; 48(4):574-85. PubMed ID: 16972708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can we inflate effect size and thus increase chances of producing "positive" results if we raise the baseline threshold in schizophrenia trials?
    Furukawa TA; Leucht S
    Schizophr Res; 2013 Mar; 144(1-3):105-8. PubMed ID: 23312551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.